Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 17;23(3):679.
doi: 10.3390/molecules23030679.

Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors

Affiliations

Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors

Oksana V Salomatina et al. Molecules. .

Abstract

An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC50 up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme.

Keywords: Tdp1 inhibitor; amide; cancer; chenodeoxycholic acid; deoxycholic acid; molecular modelling; tumor; ursodeoxycholic acid; virtual screening.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structures of reported Tdp1 inhibitors.
Scheme 1
Scheme 1
Synthesis of compound 1a,b, 2a,b and 3a,b that combine the residues of bile acids and tryptamine: reagent and conditions: (a) Ac2O, DMAP, CH2Cl2 (RT); (b) (COCl)2, DMF, CH2Cl2 (0 °C); (c) tryptamine, NEt3, CH2Cl2 (0 °C, RT); (d) KOH, MeOH (reflux); (e) KOH, MeOH (RT); (f) Ac2O, AcOH.
Scheme 2
Scheme 2
Synthesis of deoxycholic acid amides 4a,b8a,b and 9a11a: (a) (COCl)2, DMF, CH2Cl2 (0 °C); (b) tryptamine, NEt3, CH2Cl2 (0 °C, RT); (c) KOH, MeOH (reflux).
Figure 2
Figure 2
The docked configuration of 9a to the binding site of Tdp1 using the ChemPLP scoring function. (A) Hydrogen bond is depicted as a green line between the ligand and the amino acid TYR204. (B) The protein surface is rendered. The steroid group is inserted in a lipophilic pocket and the acyl groups are exposed to the water environment. Red depicts a positive partial charge on the surface, blue depicts a negative partial charge and grey shows the neutral/lipophilic areas.

References

    1. Lu J.Y.D., Su P., Barber J.E.M., Nash J.E., Le A.D., Liu F., Wong A.H.C. The neuroprotective effect of nicotine in Parkinson’s disease models is associated with inhibiting PARP-1 and caspase-3 cleavage. PeerJ. 2017;5:e3933. doi: 10.7717/peerj.3933. - DOI - PMC - PubMed
    1. Dexheimer T.S., Antony S., Marchand C., Pommier Y. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy. Anticancer Agents Med. Chem. 2008;8:381–389. doi: 10.2174/187152008784220357. - DOI - PMC - PubMed
    1. Laev S.S., Salakhutdinov N.F., Lavrik O.I. Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential. Bioorg. Med. Chem. 2016;24:5017–5027. doi: 10.1016/j.bmc.2016.09.045. - DOI - PubMed
    1. Jdey W., Thierry S., Russo C., Devun F., Al Abo M., Noguiez-Hellin P., Sun J.S., Barillot E., Zinovyev A., Kuperstein I., et al. Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors. Clin. Cancer Res. 2017;23:1001–1011. doi: 10.1158/1078-0432.CCR-16-1193. - DOI - PMC - PubMed
    1. Huang S.N., Pommier Y., Marchand C. Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors. Expert Opin. Ther. Pat. 2011;21:1285–1292. doi: 10.1517/13543776.2011.604314. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources